Home » Topics » Regulatory

Regulatory
RSS

CE Mark granted for the Prosorba Column as rheumatoid arthritis Rx

March 14, 2000

FDA approval sought for Imitrex in the treatment of adolescent migraine

March 14, 2000

Curatek begins pivotal trial of clonidine gel for neuropathic pain

March 13, 2000

The FDA approves Viadur for once-yearly palliative treatment of advanced prostate cancer

March 10, 2000

New nondrug treatment approved for rheumatoid arthritis in Canada

March 10, 2000

New formulation of Agouron's Viracept approved in U.S.

March 10, 2000

Pharmacia & Upjohn submits applications for once-daily Detrol formulation

March 10, 2000

AMBI to receive patent for use of calcium taurate with antihypertensive agents

March 10, 2000

The FDA approves once-daily Singulair tablet for treatment of asthma in young children

March 9, 2000

Solid oral formulations of eprosartan with enhanced bioavailability

March 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Flow Neuro wins FDA nod for at-home device for depression
BioWorld MedTech
Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...